As we expected, more chromatin hTERT promoter DNA were amplified in lung cancer A549 and H1299 cells and immortalized HBE cells than those in normal lung HLF cells when a CBP antibody was used in the ChIP assay (Fig. 1B), whereas nearly no DNA-binding was detected when a control normal IgG was used. Here, CREBBP is linked to lung cancer.